This program offers a unique opportunity for businesses focused on innovative research in HIV vaccine development. You can access funding to support high-risk, high-impact research that may not be feasible under traditional financing models. This allows you the freedom to explore bold ideas and contribute to groundbreaking studies that have the potential to make a real difference in public health.

Funding is provided for up to two years, but you'll only need to meet specific milestones by Year 2 to continue receiving support. This Go/No-Go approach creates a flexible funding structure, allowing you to pursue ambitious projects without heavy long-term financial commitments. Additionally, there are no caps on funding limits or revenue requirements, making this opportunity accessible to businesses of all sizes.

By applying, you can position your business at the forefront of HIV research, channeling resources into initiatives that might change lives. Your work could pave the way for significant advancements, and being part of this program means your innovations can shine.

Type of Financing
This funding opportunity provides a grant. Unlike loans, grants do not need to be repaid, making them a fantastic resource for businesses looking to invest in innovative research.

Repayment Terms and Interest Rates
Since this is a grant, there are no repayment terms or interest rates. You will receive the funding without the burden of paying it back, as long as you meet the necessary criteria along the way.

Eligible Expenses
You can use the funds for a variety of costs related to high-risk, high-impact research on vaccine development for HIV. Eligible expenses may include:

• Research supplies and materials
• Equipment purchases
• Salary support for research staff
• Other costs directly tied to the project

Ineligible Expenses
The funds cannot be used for general administrative or overhead costs that do not directly support the research.

Fees Associated with the Program
There are no direct fees associated with applying for or receiving the grant. However, it's always wise to review the specific requirements to avoid any unexpected expenses down the line.

• Location: Available across the country.
• Sectors: Open to all sectors.
• Employees: No minimum or maximum employee requirements.
• Company Revenue: No minimum or maximum revenue qualifications.
• Legal Structure: All legal structures are applicable.
• Profit Structure: All profit structures are applicable.

Disqualifications:

• There are no specified disqualifications based on the provided context.

This program is designed to back innovative research on HIV vaccine development. Your business has the chance to access funding aimed at groundbreaking studies that can make a real difference in public health. The emphasis here is on high-risk, high-reward projects, meaning you can explore new ideas that might not fit into traditional funding models.

Funding is structured around a Go/No-Go criteria approach. This means you could receive support for up to two years, but continued funding will depend on meeting the agreed milestones in Year 2. This creates a supportive environment for your business to take bold research steps without the usual long-term financial commitments.

There’s no cap on funding limits or revenue requirements, making this opportunity accessible regardless of your business size or revenue. If you're in the health or research sectors, this could be a game-changer for you. With the potential to contribute to significant advancements in HIV research, your business can help pave the way for future innovations.